Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Ingredient Progesterone Exclusively In The Dosage Form Vka, (obo) Atc G03da04 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Elbasvir + Grazoprevir, (obo) Atc J05ap54 For The Period 01.03.2025 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Nitisinone, (obo) Atc A16ax04 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Progesterone Exclusively In The Dosage Form Vka 2027-01-05
Germany Drug Discount Agreements Pursuant To Section 130a Para. 8 Sgb V Within The Framework Of Open House Procedures 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Atovaquone, (obg) Atc P01ax06 For The Period 01.03.2025 28.02.2027 2027-01-05
Germany Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Drug Name Xeomin(r), Atc M03ax21 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Pegfilgrastim, (obo) Atc L03aa13 For The Period 01.03.2025 - 28.02.2026 (plus Extension Option 1x12 Months) - Medicine 2027-01-05
Germany Drug Discount Agreements Pursuant To Section 130a Para. 8 Sgb V Within The Framework Of Open House Procedures 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Nitisinone, (obo) Atc A16ax04 For The Period 01.03.2025 28.02.2027 2027-01-05
Whats app